We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Celgene Acquire Delinia

News   Jan 27, 2017 | Original Story From Delinia

 
Celgene Acquire Delinia
 
 
 

RELATED ARTICLES

Epigenetic Treatments Could Trigger Aggressive Tumors

News

A team headed by ICREA researchers Salvador Aznar Benitah and Fran Supek concludes that care should be taken with drugs that inhibit epigenetic factors.

READ MORE

10-20% of Cells in a Kidney Organoid Found to be Non-Renal

News

Single-cell transcriptomics revealed 10-20% of cells in a kidney organoid were non-renal cells.

READ MORE

Molecule Could Transform the Treatment of Diabetes

News

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE